Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the only FDA-cleared diagnostic blood test that provides 98% accurate, actionable, objective quantification of blood volume status and composition compared to patient-specific norms. In a randomized control trial, BVA changed SICU fluid and red blood cell interventions in 44% of cases, reduced mortality by 66% and patients’ length of stay and days on a ventilator. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume.